Hidehito Horinouchi

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  

Hidehito Horinouchi
Mar 25, 2025, 19:50 | Blog
Hidehito Horinouchi: Amivantamab plus Lazertinib vs. Osimertinib in 1L EGFRm Advanced NSCLC
Hidehito Horinouchi, Assistant Chief at National Cancer Center Hospital, shared on X: "Now Out: MARIPOSA…
Mar 4, 2025, 09:25 | Blog
Hidehito Horinouchi: Oral - Lung / Thoracic Cancer 1
Hidehito Horinouchi, Assistant Chief of the National Cancer Center Hospital, shared a post on X:…
Feb 11, 2025, 07:51 | Science
Hiding in plain sight: NUT carcinoma is an unrecognized subtype of squamous cell carcinoma of the lungs and head and neck
Hidehito Horinouchi, Assistant Chief of the National Cancer Center Hospital, shared an article by Jia…
Feb 7, 2025, 14:07 | Science
Hidehito Horinouchi: iDFS reliably predicts final OS in breast cancer
Hidehito Horinouchi, Assistant Chief of the National Cancer Center Hospital, shared a post on X…
Feb 4, 2025, 16:09 | Science
Hidehito Horinouchi: Enhancing performance of automatic trial matching tools in molecular tumor boards
Hidehito Horinouchi, Assistant Chief of the National Cancer Center Hospital, shared a post on X…
Jan 29, 2025, 22:05 | Blog
Teliso-V and osimertinib: the METamorphosis of EGFR-mutant lung cancer?
Hidehito Horinouchi, Assistant Chief of the National Cancer Center Hospital, shared a post on X:…
Jan 23, 2025, 15:28 | Science
Summary of the intrinsic, extrinsic and systemic factors developing ‘cold’ tumors
Hidehito Horinouchi, Assistant Chief of the National Cancer Center Hospital, shared an article by Kaili…
Jan 21, 2025, 06:22 | Insight
Biological and clinical significance of tumour-infiltrating lymphocytes in the era of immunotherapy
A recent paper by Miguel Lopez de Rodas, Associate Research Scientist in Pathology at Yale Cancer…
Jan 16, 2025, 08:42 | Insight
Hidehito Horinouchi: Telisotuzumab Vedotin and Osimertinib in EGFR-Mutated NSCLC
Hidehito Horinouchi, Assistant Chief of the National Cancer Center Hospital, shared a post on X…
Jan 13, 2025, 22:32 | Insight
Highlights from TASLC 2025 International Symposium by Hidehito Horinouchi
The Taiwan Association for the Study of Lung Cancer (TASLC) 2025 International Symposiam was held from…
Jan 13, 2025, 17:02 | Blog
Hidehito Horinouchi: TASLC25 International Symposium
Hidehito Horinouchi, Assistant Chief of the National Cancer Center Hospital, shared a post on X:…
Jan 13, 2025, 15:20 | Science
Hidehito Horinouchi: Controversies in Thoracic Oncology
Hidehito Horinouchi, Assistant Chief of the National Cancer Center Hospital, shared a post on X,…
Jan 13, 2025, 04:50 | Insight
Hidehito Horinouchi: Potential long-term clinical benefit from CheckMate 816
Hidehito Horinouchi, Assistant Chief of the National Cancer Center Hospital, shared a post on X…
Jan 9, 2025, 11:42 | Insight
Hidehito Horinouchi: ATORG expert consensus statement on the peri-operative management of NSCLC
A recent paper by Stephanie Saw, Medical Oncologist at National Cancer Centre Singapore, was mentioned…
Dec 13, 2024, 13:32 | Blog
OncoInfluencers to Follow on Social Media: Dr. Hidehito Horinouchi
We’re excited to feature Dr. Hidehito Horinouchi, a distinguished leader in thoracic oncology, as our…
Dec 2, 2024, 09:46 | Positive
Top 100 Xfluencers in Lung Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024
As November came to a close, it's an ideal time to reflect on Lung Cancer…
Nov 22, 2024, 22:09 | Insight
5 papers about Lung Cancer suggested by Stephen Liu
Stephen Liu, Associate Professor at Georgetown Lombardi Comprehensive Cancer Center, shared a few must-reads papers…
Nov 3, 2024, 09:30 | Blog
Hidehito Horinouchi: Proud to be Mentoring Japan's Rising Star Masahiro Torasawa
Hidehito Horinouchi posted on X: "Proud to be Mentoring Japan's Rising Star Masahiro Torasawa Distinguished…
Nov 1, 2024, 17:46 | Blog
Hidehito Horinouchi: Early Stage NSCLC at ACLC24 session
Hidehito Horinouchi, Assistant Chief of the National Cancer Center Hospital, shared a post on X:…
Oct 21, 2024, 17:17 | Societies
Highlights from ACLC 2024
The 2024 Asia Conference on Lung Cancer (ACLC 2024) took place from October 17 to…
Oct 18, 2024, 16:55 | Blog
Hidehito Horinouchi: THREE reasons to attend ACLC24
Hidehito Horinouchi posted on X: "Arriving Hong Kong from Tokyo ACLC24 THREE reasons to attend Update…
Oct 18, 2024, 13:52 | Insight
Hidehito Horinouchi: Oral Abstract Session 1 at ACLC24
Hidehito Horinouchi, Assistant Chief of the National Cancer Center Hospital, shared a post on X:…
Oct 17, 2024, 16:24 | Blog
Hidehito Horinouchi: Articles from the ACLC 24
Hidehito Horinouchi shared a post on X: "ACLC 24 IASLC Asia Plenary: Showcase of Best Abstracts…
Oct 16, 2024, 17:10 | Blog
Hidehito Horinouchi: Collaborative Workshop on Advancing Lung Cancer Screening Implementation in Asia Pacific
Hidehito Horinouchi shared a post on X: "ACLC24 Asia. Collaborative Workshop on Advancing Lung Cancer…
Oct 1, 2024, 12:21 | Blog
Sanjay Popat: Delighted to be giving a keynote address on Lung Cancer at KSMO2024
Sanjay Popat, Thoracic Oncologist at The Royal Marsden NHS Foundation Trust, Professor at The ICR,…
Sep 30, 2024, 14:33 | Blog
Hidehito Horinouchi: Welcoming participants from Korea and around the world to Kobe
Hidehito Horinouchi shared a post on X: ''KSMO2024, JSMO2025 booth We welcome korean and world…
Sep 15, 2024, 01:34 | Insight
Some perspective on TRUST-II with talectrectinib
IASLC shared on X: “ In this episode, Narjust Florez and Stephen V Liu, recap…
Sep 14, 2024, 06:41 | Societies
Best of WCLC24
The WCLC24 took place at the San Diego Convention Center from September 7 to 10,…
Sep 12, 2024, 16:26 | Societies
35 posts not to miss from WCLC24 Day 4
The WCLC24 is took place at the San Diego Convention Center from September 7 to…
Sep 4, 2024, 16:17 | Blog
Hidehito Horinouchi: Social Media and Communications Workshop at WCLC24
Hidehito Horinouchi shared a post on X: ''WCLC24. Social Media and Communications Workshop. Faculties: Matthew Smeltzer,…
Sep 4, 2024, 15:28 | Blog
Hidehito Horinouchi: Early Career Investigator Workshop at WCLC24
Hidehito Horinouchi shared a post on X: ''WCLC24. Early Career Investigator Workshop. Faculties: Narjust Florez, Fabio…
Aug 29, 2024, 17:01 | Insight
Elad Sharon: Quite promising for c-MET over-expressing NSCLC
Elad Sharon, Medical Oncologist at Dana-Farber Cancer Institute, shared a post by Giuseppe Banna, Consultant…
Aug 27, 2024, 22:06 | Insight
Giuseppe Banna: Promising results for Telisotuzumab Vedotin in advanced NSCLC
Giuseppe Banna, Consultant Medical Oncologist at Portsmouth Hospitals University NHS Trust, shared a post on…
Aug 24, 2024, 20:21 | Insight
Hidehito Horinouchi summarizes some abstracts of WCLC24 part 3
Hidehito Horinouchi shared on X: Advancing Multimodal Therapies in Stage III NSCLC Chairs: Feng-Ming Spring Kong,…
Aug 18, 2024, 06:32 | Blog
Hidehito Horinouchi summarizes some abstracts of WCLC24 part 2
Hidehito Horinouchi shared on X: "Trailblazing Targets: New Insights Chairs: Drs. Jacob Sands and Lorenza Landi.…
Aug 16, 2024, 12:23 | Societies
Hidehito Horinouchi summarizes some abstracts of WCLC24
Hidehito Horinouchi shared on X: Antibody Drug Conjugates in SCLC by Charlie Rudin Ifinatamab Deruxtecan…
Aug 14, 2024, 03:35 | Insight
Hidehito Horinouchi: Presidential 2, WCLC24 abstracts titles
Hidehito Horinouchi, Oncologist at the Department of Thoracic Oncology at the National Cancer Center Hospital,…
Aug 13, 2024, 20:25 | Insight
Hidehito Horinouchi: Impact of Durvalumab on corticosteroid therapy for pneumonitis after chemoradiotherapy
Hidehito Horinouchi, Oncologist at the Department of Thoracic Oncology at the National Cancer Center Hospital,…
Aug 12, 2024, 14:04 | Blog
Hidehito Horinouchi: WCLC24 abstracts titles - Presidential 1
Hidehito Horinouchi, Oncologist at the Department of Thoracic Oncology at the National Cancer Center Hospital,…
Aug 10, 2024, 09:08 | Societies
12 Posts Not To Miss From Day 2 of ASCOBT24!
This Year the ASCO Breakthrough (ASCOBT24) is being held in Yokohama, Japan from 8th to…
Aug 9, 2024, 06:38 | Societies
15 Posts Not To Miss From Day 1 of ASCOBT24!
The ASCO Breakthrough (ASCOBT24) is being held in Yokohoma, Japan from 8th to 10th August…
Aug 7, 2024, 16:37 | Blog
2024 ASCO Breakthrough Featured Voices
The ASCO Breakthrough conference, hosted by the American Society of Clinical Oncology (ASCO), is a…
Aug 6, 2024, 11:58 | Insight
Hidehito Horinouchi: ASCO Breakthrough 2024 is in 2 days
Hidehito Horinouchi, Oncologist at the Department of Thoracic Oncology at the National Cancer Center Hospital,…
Jun 1, 2024, 10:17 | Blog
Hidehito Horinouchi: HARMONi-A - Chemo +/- Ivonescimab in EGFRm NSCLC after EGFR-TKIs resistance
Hidehito Horinouchi, Oncologist at the Department of Thoracic Oncology at the National Cancer Center Hospital,…
Apr 28, 2024, 16:38 | Blog
Hidehito Horinouchi: Abstract Titles Clinical Science Symposium: Targeting KRAS in NSCLC
Hidehito Horinouchi,  Oncologist at the Department of Thoracic Oncology at the National Cancer Center Hospital, shared a…
Feb 26, 2024, 09:51 | Blog
Hidehito Horinouchi: Thank you so much Solange Peters for coming to Japan
Hidehito Horinouchi, Medical Oncologist, Assistant Chief in the Department of Thoracic Oncology at National Cancer Center…
Nov 1, 2023, 18:54 | Societies
20 Posts Not To Miss From ESMO 2023 Congress
The Annual Congress of the European Society For Medical Oncology (ESMO) took place from October…
Sep 27, 2023, 16:57 | Blog
Hidehito Horinouchi: Reconsidering the cutoff for sensitive and refractory relapses in ES-SCLC in the era of ICIs in JTO and JTO CRR by Dr. Masahiro Torasawa.
Hidehito Horinouchi, Assistant Chief of the Department of Thoracic Oncology at National Cancer Center Hospital,…
Sep 14, 2023, 18:08 | Blog,Stories
Top 9 posts you dont wanna wiss from WCLC
The 2023 World Conference on Lung Cancer took place in Singapore from September 9-12. Our…
Aug 4, 2023, 09:15 | Blog
10 Tweets from ASCOBT23 not to miss
ASCO Breakthrough (ASCOBT23) is being held in Yokohama, Japan, and online from August 3 to…
Jun 26, 2023, 19:04 | Blog
We are pleased to announce the formulation of the Asia Pacific Coalition Against Lung Cancer
In a post by Asia Pacific Coalition against Lung Cancer on Linkedin, it says, "We…
All: 51 Posts: 1 - 100
Special Coverage